Literature DB >> 16022968

Steps toward the percutaneous replacement of atrioventricular valves an experimental study.

Younes Boudjemline1, Gabriella Agnoletti, Damien Bonnet, Luc Behr, Nicolas Borenstein, Daniel Sidi, Philipp Bonhoeffer.   

Abstract

OBJECTIVES: The goal of this study was to develop a device for percutaneous replacement of the tricuspid valve in animals.
BACKGROUND: Percutaneous valve replacement has recently been introduced, and early clinical experience has been reported. To date, this technique is limited to the replacement of pulmonary and aortic valves in selected patients.
METHODS: A newly designed nitinol stent, forming two large disks separated by a cylinder with a diameter of 18 mm, was specially designed for the purpose of this study. An 18-mm bovine valve was mounted in the central part of the stent, and a polytetrafluoroethylene membrane was sutured onto the ventricular disk. Eight ewes were equally divided into two groups (group 1, acute study; group 2, killed at one month).
RESULTS: Seven of eight devices were successfully delivered in the desired position. In one animal, the device was trapped in tricuspid cordae, leading to its incomplete opening. A significant paravalvular leak was noticed in one animal of group 2. Mean right atrial pressure increased from 5 to 7 mm Hg and did not change during the follow-up. At autopsy, examination confirmed the good position of devices in successfully implanted animals.
CONCLUSIONS: Implantation of a semi-lunar valve in the tricuspid position is possible in ewes through a transcatheter approach. A disk-based nitinol stent is needed to allow valve implantation in the atrioventricular position. These studies open new perspectives into tricuspid as well as mitral valve replacement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16022968     DOI: 10.1016/j.jacc.2005.01.063

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  21 in total

Review 1.  Tricuspid regurgitation: pathophysiology and management.

Authors:  Rashmi Thapa; Buddhadeb Dawn; Jayant Nath
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

2.  Current status of percutaneous valvular procedures.

Authors:  Dominique Himbert; Eric Brochet; David Messika-Zeitoun; Alec Vahanian
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-11

3.  Real-time interactive MRI-guided cardiac surgery: aortic valve replacement using a direct apical approach.

Authors:  Elliot R McVeigh; Michael A Guttman; Robert J Lederman; Ming Li; Ozgur Kocaturk; Timothy Hunt; Shawn Kozlov; Keith A Horvath
Journal:  Magn Reson Med       Date:  2006-11       Impact factor: 4.668

Review 4.  New percutaneous treatments for valve disease.

Authors:  Louise Coats; Philipp Bonhoeffer
Journal:  Heart       Date:  2007-05       Impact factor: 5.994

Review 5.  Echocardiographic assessment and clinical management of tricuspid regurgitation.

Authors:  Nicole M Bhave; R Parker Ward
Journal:  Curr Cardiol Rep       Date:  2011-06       Impact factor: 2.931

6.  Quantification of biomechanical interaction of transcatheter aortic valve stent deployed in porcine and ovine hearts.

Authors:  Joseph Mummert; Eric Sirois; Wei Sun
Journal:  Ann Biomed Eng       Date:  2012-11-17       Impact factor: 3.934

Review 7.  [Interventions at the tricuspid valve: What is possible?].

Authors:  Alexander Lauten; H-R Figulla
Journal:  Herz       Date:  2015-08       Impact factor: 1.443

Review 8.  How to Treat Tricuspid Valve Disease: What's New on the Horizon?

Authors:  Karina Brüstle; Christelle Calen; Shingo Kuwata; Fabian Nietlispach; Michel Zuber; Francesco Maisano; Maurizio Taramasso
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-03

9.  Percutaneous pulmonary and tricuspid valve implantations: An update.

Authors:  Robert Wagner; Ingo Daehnert; Philipp Lurz
Journal:  World J Cardiol       Date:  2015-04-26

10.  Quantification of structural compliance of aged human and porcine aortic root tissues.

Authors:  Kewei Li; Qian Wang; Thuy Pham; Wei Sun
Journal:  J Biomed Mater Res A       Date:  2013-09-02       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.